LTR Pharma Limited (AU:LTP) has released an update.
LTR Pharma Limited (ASX:LTP) has requested a trading halt on its securities as it prepares to announce a significant capital raise. The halt will remain in effect until the announcement is released or when normal trading resumes on Wednesday, 24 July 2024. The company specializes in men’s health and is known for SPONTAN®, a rapid-action nasal spray treatment for Erectile Dysfunction.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
